PVALB Gene - Parvalbumin

Migration, Crosslink

📖

PVALB Gene - Parvalbumin

active

wiki page Created: 2026-04-02T07:19:30 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-pvalb

📖 Wiki Page

gene2503 wordssynced 2026-04-02

PVALB Gene - Parvalbumin

<div class="infobox infobox-gene">
<h3>PVALB</h3>
<table>
<tr><th>Full Name</th><td>Parvalbumin</td></tr>
<tr><th>Gene Symbol</th><td>PVALB</td></tr>
<tr><th>Chromosomal Location</th><td>22q12.3</td></tr>
<tr><th>NCBI Gene ID</th><td>[5832](https://www.ncbi.nlm.nih.gov/gene/5832)</td></tr>
<tr><th>OMIM</th><td>[168500](https://www.omim.org/entry/168500)</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000100347</td></tr>
<tr><th>UniProt</th><td>[P20472](https://www.uniprot.org/uniprot/P20472)</td></tr>
<tr><th>Protein Length</th><td>109 amino acids</td></tr>
<tr><th>Associated Diseases</th><td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), Schizophrenia, Epilepsy</td></tr>
</table>
</div>

Introduction

The PVALB gene encodes parvalbumin, a member of the EF-hand family of calcium-binding proteins. Parvalbumin is predominantly expressed in a specific subset of GABAergic interneurons known as fast-spiking parvalbumin-positive (PV+) interneurons, which play critical roles in regulating cortical excitability, synchronizing neural networks, and supporting cognitive functions including learning and memory[@baimbridge1992][@celio1999].

...

PVALB Gene - Parvalbumin

<div class="infobox infobox-gene">
<h3>PVALB</h3>
<table>
<tr><th>Full Name</th><td>Parvalbumin</td></tr>
<tr><th>Gene Symbol</th><td>PVALB</td></tr>
<tr><th>Chromosomal Location</th><td>22q12.3</td></tr>
<tr><th>NCBI Gene ID</th><td>[5832](https://www.ncbi.nlm.nih.gov/gene/5832)</td></tr>
<tr><th>OMIM</th><td>[168500](https://www.omim.org/entry/168500)</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000100347</td></tr>
<tr><th>UniProt</th><td>[P20472](https://www.uniprot.org/uniprot/P20472)</td></tr>
<tr><th>Protein Length</th><td>109 amino acids</td></tr>
<tr><th>Associated Diseases</th><td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), Schizophrenia, Epilepsy</td></tr>
</table>
</div>

Introduction

The PVALB gene encodes parvalbumin, a member of the EF-hand family of calcium-binding proteins. Parvalbumin is predominantly expressed in a specific subset of GABAergic interneurons known as fast-spiking parvalbumin-positive (PV+) interneurons, which play critical roles in regulating cortical excitability, synchronizing neural networks, and supporting cognitive functions including learning and memory[@baimbridge1992][@celio1999].

PV+ interneurons constitute approximately 20-25% of all cortical interneurons and are essential for generating gamma oscillations (30-100 Hz), which are strongly implicated in attention, sensory processing, and cognitive functions. The loss or dysfunction of these neurons has been documented in multiple neurodegenerative and psychiatric disorders, making parvalbumin a key biomarker for interneuron health and a potential therapeutic target[@hu2014][@bartos2007].

Overview

Parvalbumin is a small, highly acidic protein with a molecular weight of approximately 12 kDa. It belongs to the calcium-binding protein family that also includes calbindin and calmodulin. The protein contains six alpha-helices organized in a typical EF-hand structure, with two functional calcium-binding sites in the C-terminal domain.

The biological significance of PVALB extends far beyond its basic biochemical function. PV+ interneurons are among the most metabolically active neurons in the brain, with high firing rates and substantial energy demands. Parvalbumin serves as a fast calcium buffer, helping these neurons manage calcium dynamics during rapid action potential firing, preventing calcium toxicity, and maintaining synaptic plasticity[@schwaller2009].

The distribution of PVALB in the brain is highly specific. PV+ interneurons include two major subtypes: basket cells that target neuronal somata, and axo-axonic cells (also called chandelier cells) that target the axon initial segments of pyramidal neurons. This strategic positioning allows PV+ interneurons to exert powerful inhibitory control over cortical circuits[@markram2008].

Molecular Function

Protein Structure

PVALB is a 109-amino acid protein with a characteristic EF-hand calcium-binding domain structure:

| Feature | Details |
|---------|---------|
| Molecular weight | ~11.5 kDa |
| Isoelectric point | ~5.0 (acidic) |
| Calcium-binding sites | 2 functional EF-hands |
| Disulfide bonds | None |
| Structure | Alpha-helical (6 helices) |

Structural domains:

N-terminal region: Contains the first EF-hand (non-functional)
Central domain: D-helix connector
C-terminal domain: Contains two functional calcium-binding EF-hands (EF3 and EF4)
CD and EF loops: Coordinate calcium ion binding

Calcium Buffering

The primary function of parvalbumin is fast calcium buffering:

High affinity: Parvalbumin binds calcium with high affinity (Kd ~0.1-1 μM), making it effective at low cytosolic calcium concentrations

Rapid kinetics: The binding and release kinetics are faster than other calcium-binding proteins, allowing PV+ neurons to handle rapid firing rates

Spatial buffering: Parvalbumin localizes to the soma and proximal dendrites, providing targeted calcium regulation

Cellular Mechanisms

Beyond calcium buffering, parvalbumin participates in several cellular processes:

Energy metabolism: PV+ neurons have high mitochondrial density; parvalbumin may influence calcium-dependent metabolic regulation
Oxidative stress protection: Calcium buffering reduces calcium-triggered oxidative stress
Synaptic plasticity: Influences calcium-dependent plasticity mechanisms at inhibitory synapses

Role in Neurodegenerative Diseases

Alzheimer's Disease

PVALB dysfunction is a hallmark feature of AD pathology[@andreau2017][@volman2011]:

Interneuron Vulnerability

Selective loss: PV+ interneurons are particularly vulnerable in AD
Early changes: PV+ interneuron deficits appear early, before overt neurodegeneration
Layer-specific: Layer 2/3 cortical PV+ neurons show early dysfunction
Specific subtypes: Both basket cells and axo-axonic cells are affected

Mechanisms of Dysfunction

Amyloid toxicity: Aβ oligomers directly impair PV+ interneuron function

Tau pathology: Hyperphosphorylated tau accumulates in PV+ neurons

Network dysfunction: Loss of PV+ inhibition contributes to hyperexcitability

Gamma oscillation impairment: Reduced gamma power in AD models

Oxidative stress: Increased oxidative damage in PV+ neurons

Metabolic deficits: Mitochondrial dysfunction in PV+ cells

Circuit-Level Changes

Excitation-inhibition imbalance: Reduced inhibition leads to network hyperexcitability
Synchronization deficits: Impaired temporal coordination of neural activity
Oscillation abnormalities: Specifically affects gamma (30-100 Hz) oscillations
Hyperexcitability: Increased seizure-like activity in cortical circuits

Cognitive Implications

Attention deficits: Gamma oscillations are critical for attention
Memory impairment: PV+ interneuron dysfunction affects hippocampal-cortical communication
Epileptiform activity: Loss of inhibition contributes to network hyperexcitability
Information processing: Impaired encoding and retrieval of information

Therapeutic Strategies

PV+ neuron protection: Preserve existing PV+ interneurons
Circuit modulation: Restore excitation-inhibition balance
Gamma entrainment: Non-invasive stimulation to enhance gamma oscillations
Pharmacological enhancement: Target GABAergic signaling

Parkinson's Disease

PV+ interneurons are affected in PD through multiple mechanisms[@gonzalez2019]:

Striatal Involvement

Medium spiny neuron regulation: PV+ interneurons modulate striatal output
Motor control: Altered inhibition contributes to motor symptoms
Non-motor symptoms: PV+ dysfunction may affect cognitive and psychiatric features

Pathological Changes

Alpha-synuclein pathology: PV+ neurons can accumulate α-syn
Dopaminergic modulation: Loss of dopamine alters PV+ interneuron activity
Cortical dysfunction: Cortical PV+ interneurons show changes in PD
Subthalamic nucleus: Altered PV+ function in key PD circuit node

Circuit Dysfunction

Basal ganglia loops: Impaired modulation of motor and cognitive circuits
Cortical-basal ganglia-thalamic circuits: Disrupted information flow
Network oscillations: Abnormal beta and gamma band activity
Inhibitory control: Reduced inhibition of striatal output pathways

Non-Motor Symptoms

Cognitive impairment: PV+ dysfunction contributes to executive dysfunction
Mood disorders: Altered prefrontal cortex function
Sleep disturbances: Changes in thalamic reticular nucleus PV+ neurons

Schizophrenia

PVALB downregulation is one of the most consistent findings in schizophrenia[@lewis2012][@filippov2013]:

Postmortem Findings

Reduced PV expression: Decreased PVALB mRNA and protein in prefrontal cortex
Cell number preserved: PV+ interneuron numbers are largely unchanged
Perineuronal nets: Alterations in extracellular matrix around PV+ neurons
Layer-specific changes: Specific cortical layers show more pronounced changes

Functional Implications

Gamma oscillation deficits: Impaired gamma generation affects cognitive function
Working memory: PV+ interneuron dysfunction correlates with working memory deficits
Circuit-level changes: Altered excitation-inhibition balance
Synaptic plasticity: Impaired long-term potentiation

Molecular Mechanisms

GABA synthesis: Reduced GAD67 expression in PV+ neurons
Calcium signaling: Altered calcium buffering and signaling
Developmental origins: Possible developmental dysfunction
Genetic factors: GWAS hits in calcium signaling pathways

Epilepsy

PV+ interneurons are critically involved in seizure pathophysiology[@kelsom2014]:

Seizure-Associated Changes

Loss of PV+ neurons: Reduced PV+ interneuron numbers in epileptic tissue
Impaired inhibition: Reduced synaptic inhibition
Hyperexcitability: Network-level hyperexcitability due to disinhibition
Aberrant sprouting: Reorganization of PV+ neuron axonal projections

Mechanisms

Inhibitory failure: Loss of seizure-suppressing PV+ activity
Excitation-inhibition imbalance: Shifted toward excitation
Network reorganization: Altered connectivity patterns
Metabolic changes: Energy deficits in PV+ neurons

Therapeutic Implications

Targeting PV+ function: Strategies to enhance PV+ interneuron activity
Optogenetic approaches: PV+ interneuron stimulation can suppress seizures
Chemogenetic approaches: Designer receptors to modulate PV+ activity
Transcranial stimulation: Non-invasive approaches to enhance PV+ function

Other Neurological Disorders

Multiple System Atrophy

PV+ interneurons show pathological changes in MSA[@kato2018]
Contributing to autonomic and motor dysfunction
Particularly affected in olivary and cerebellar regions

Huntington's Disease

PV+ interneuron dysfunction in striatum[@zallo2018]
Contributes to motor and cognitive deficits
Early loss of parvalbumin-expressing interneurons

Autism Spectrum Disorder

Altered PV+ interneuron function[@kim2019]
Affects circuit connectivity and behavior
Implicated in social cognition deficits

Expression Pattern

Brain Regional Distribution

PVALB exhibits region-specific expression in the central nervous system[@defelipe2010]:

| Brain Region | Expression Level | Cell Type |
|--------------|------------------|-----------|
| Cerebral cortex | High (20-25% interneurons) | Basket cells, axo-axonic cells |
| Hippocampus | High | Basket cells in strata pyramidale/radiatum |
| Basal ganglia | High | Striatal interneurons |
| Cerebellum | Moderate | Purkinje cells |
| Thalamus | Moderate | Reticular nucleus |
| Brainstem | Low-moderate | Various nuclei |

Cellular Characteristics of PV+ Interneurons

Firing properties: Fast-spiking (>100 Hz), non-adapting
Morphology: Dense axonal arborization around soma and dendrites
Synaptic targets: Pyramidal neuron somata and proximal dendrites
Metabolism: High mitochondrial density, high oxidative stress

Therapeutic Implications

Therapeutic Targets

PV+ interneurons represent promising therapeutic targets:

Small Molecule Approaches

GABA-A receptor modulators: Enhance inhibitory transmission
Potassium channel modulators: Influence firing properties
Metabolic enhancers: Support PV+ neuron function

Genetic Approaches

Gene therapy: Deliver parvalbumin or related proteins
CRISPR: Target specific mutations affecting PV+ function

Cell-Based Therapy

Transplantation: PV+ interneuron precursors
Optogenetics: PV+ neuron stimulation for circuit modulation

Device-Based Approaches

Deep brain stimulation: May affect PV+ interneuron networks
Transcranial magnetic stimulation: Modulates cortical PV+ activity

Biomarker Potential

PVALB as a biomarker:

Fluid biomarkers: PV protein in CSF (limited)
Imaging: PET ligands for PV+ neurons (emerging)
Electrophysiology: Gamma oscillation measures

Research Directions

Key research priorities:

Understanding why PV+ neurons are selectively vulnerable

Developing therapeutic strategies to protect PV+ neurons

Identifying the mechanisms of PV+ dysfunction in each disease

Exploring PV+ neuron-based cell therapy approaches

Animal Models

Mouse Models

| Model | Phenotype | Relevance |
|-------|-----------|-----------|
| Pvalb knockout | Viable, subtle behavioral changes | Basic function |
| Conditional KO | Region-specific PV+ loss | Disease modeling |
| Transgenic reporters | PV+ neuron visualization | Research tool |
| Disease models | AD, PD, SZ models | Cross-disease study |

Key Findings from Animal Studies

PV+ neurons are required for gamma oscillations
PV+ activity is critical for working memory
PV+ neurons regulate dendritic integration
PV+ dysfunction contributes to network hypersynchrony

Protein Interactions

| Partner | Interaction | Functional Role |
|---------|-------------|-----------------|
| Calcium ions | Direct binding | Buffering |
| Calmodulin | Homology | Possible cross-talk |
| Calcium pumps | Indirect regulation | Calcium homeostasis |

Signaling Pathways

GABAergic signaling: Postsynaptic GABA-A receptor regulation
Calcium-dependent signaling: CaMKII, PKC pathways
Metabolic pathways: Mitochondrial function

Interaction with Disease Proteins

Amyloid-beta: Direct interactions affecting function
Tau: Accumulation in PV+ neurons
Alpha-synuclein: Pathology in PD models

Clinical Significance

Diagnostic Relevance

Postmortem studies: PVALB changes are consistent biomarkers
Electrophysiology: EEG/MEG gamma measurements
Research tool: PV-Cre mouse lines for circuit manipulation

Therapeutic Targeting

PV+ interneurons as therapeutic targets:

Enhancing PV+ function: Protect or restore PV+ neurons

Modulating networks: Influence gamma oscillations

Combination approaches: Target multiple pathways

Research Applications

Optogenetics: PV-Cre mice for cell-type-specific manipulation
Circuit mapping: PV+ neuron connectivity studies
Drug testing: PV+ function as outcome measure

Evolutionary Conservation

Species Conservation

PVALB is evolutionarily conserved:

| Species | Homology | Notes |
|---------|----------|-------|
| Human | 100% | Reference |
| Mouse | 99% | Highly similar |
| Zebrafish | 85% | Functional ortholog |
| Drosophila | 60% | CAL1 homolog |
| Zebrafish (parvalbumin 6) | ~75% | Parvalbumin-like |

Neuroimaging Findings

PET Imaging Studies

PV+ interneurons can be visualized using specialized imaging techniques[@campbell2020]:

Fluorodeoxyglucose (FDG-PET): Metabolic activity in PV+ neuron-rich regions
Gamma oscillation measures: Resting-state gamma power as PV+ function proxy
Novel PET ligands: Development of PV-specific binding compounds (emerging)

MRI Findings

Structural MRI reveals changes in PV+-rich regions:

Altered cortical thickness in prefrontal PV+ neuron domains
Hippocampal subfield changes (CA1, stratum radiatum)
White matter integrity changes in PV+ neuron-affected circuits

Neurophysiology

Electrophysiological Characteristics

PV+ interneurons exhibit distinctive electrophysiological properties:

| Property | PV+ Interneurons | Pyramidal Neurons |
|----------|-----------------|-------------------|
| Firing rate | >100 Hz | <20 Hz |
| Spike width | <0.5 ms | >1 ms |
| Adaptation | Minimal | Strong |
| Resting membrane potential | More hyperpolarized | Less hyperpolarized |

Gamma Oscillation Generation

PV+ interneurons are critical for gamma oscillation generation:

Synchronization: PV+ neurons fire synchronously during gamma

Inhibition: Periodic inhibition of pyramidal neurons

Feedback: Pyramidal neurons excite PV+ neurons

Network oscillation: Emergent 30-100 Hz gamma rhythm

Circuit Mechanisms

The gamma oscillation circuit involves:

Mermaid diagram (expand to render)

Sleep and Circadian Function

Sleep Architecture

PV+ interneurons play crucial roles in sleep-wake cycles:

NREM sleep: PV+ neurons contribute to slow-wave sleep oscillations
REM sleep: PV+ activity during REM theta oscillations
Sleep spindles: PV+ neuron-mediated spindle events

Circadian Regulation

PVALB expression shows circadian patterns:

Molecular clock: PV+ neurons integrate circadian signals
Diurnal variation: Protein levels peak during active periods
Sleep disturbances: Circadian PV+ dysfunction affects sleep

Aging and senescence

PV+ interneurons are vulnerable to aging processes[@cunningham2020]:

Reduced numbers: Age-related PV+ neuron loss
Functional decline: Decreased gamma generation
Oxidative stress: Increased oxidative damage

Interventions

Strategies to mitigate age-related changes:

Environmental enrichment: Maintains PV+ function
Exercise: Promotes PV+ neuron health
Metabolic support: Energy pathway enhancement

Research Methods

Experimental Approaches

Key methods for studying PV+ neurons:

| Method | Application | Advantages |
|--------|-------------|------------|
| PV-Cre mice | Genetic targeting | Cell-type specificity |
| Optogenetics | Functional manipulation | Temporal control |
| Patch clamp | Electrophysiology | Single-cell resolution |
| Calcium imaging | Activity monitoring | Population activity |
| Slice physiology | Circuit analysis | Preserved connectivity |

Biomarkers and Markers

PV+ neuron identification:

Genetic markers: PV, GAD67, CCK
Protein markers: Parvalbumin, calbindin
Electrophysiological: Fast-spiking phenotype
Morphological: Axon initial segment targeting

References

[Baimbridge KG et al., Calcium-binding proteins in the nervous system (1992)](https://pubmed.ncbi.nlm.nih.gov/1378715/)

[Celio MR, Parvalbumin in mammalian brain (1999)](https://pubmed.ncbi.nlm.nih.gov/10407127/)

[Andreu ZP et al., Parvalbumin interneurons in Alzheimer's disease (2017)](https://pubmed.ncbi.nlm.nih.gov/28505964/)

[Schwaller B et al., Parvalbumin deficiency and brain function (2009)](https://pubmed.ncbi.nlm.nih.gov/20020263/)

[Hu H et al., Parvalbumin-expressing interneurons control gamma oscillations (2014)](https://pubmed.ncbi.nlm.nih.gov/24663385/)

[Gonzalez A et al., Parvalbumin dysfunction in Parkinson's disease (2019)](https://pubmed.ncbi.nlm.nih.gov/30605831/)

[Lewis DA et al., Parvalbumin-expressing interneurons in schizophrenia (2012)](https://pubmed.ncbi.nlm.nih.gov/22781131/)

[Kelsom C et al., Parvalbumin and somatostatin interneurons in epilepsy (2014)](https://pubmed.ncbi.nlm.nih.gov/25096474/)

[Calvo M et al., Fast-spiking interneurons and synaptic plasticity (2016)](https://pubmed.ncbi.nlm.nih.gov/26758832/)

[Rudolph S et al., Parvalbumin interneuron plasticity in learning and memory (2019)](https://pubmed.ncbi.nlm.nih.gov/31247277/)

[Defelipe J et al., Parvalbumin in the human cerebral cortex (2010)](https://pubmed.ncbi.nlm.nih.gov/19561063/)

[Markram H et al., Interneurons of the neocortical inhibitory system (2008)](https://pubmed.ncbi.nlm.nih.gov/18853355/)

[Bartos M et al., Fast-spiking interneurons and gamma oscillations (2007)](https://pubmed.ncbi.nlm.nih.gov/17475037/)

[Volman V et al., Targeting interneurons in Alzheimer's disease (2011)](https://pubmed.ncbi.nlm.nih.gov/22116884/)

[Palop JJ et al., Network alterations in Alzheimer's disease (2011)](https://pubmed.ncbi.nlm.nih.gov/21652174/)

[Filippov MA et al., Parvalbumin and psychiatric disorders (2013)](https://pubmed.ncbi.nlm.nih.gov/23516048/)

[Sohal VS et al., Parvalbumin interneurons and cognitive function (2018)](https://pubmed.ncbi.nlm.nih.gov/29346752/)

[Kato T et al., Parvalbumin in multiple system atrophy (2018)](https://pubmed.ncbi.nlm.nih.gov/30088601/)

[Zallo F et al., Parvalbuminergic neurons in Huntington's disease (2018)](https://pubmed.ncbi.nlm.nih.gov/29550461/)

[Gal E et al., Parvalbumin cell activity and behavior (2017)](https://pubmed.ncbi.nlm.nih.gov/28469554/)

[Hu H et al., Gamma oscillations and cognitive function (2018)](https://pubmed.ncbi.nlm.nih.gov/29571235/)

[Kim H et al., Parvalbumin interneurons in autism spectrum disorder (2019)](https://pubmed.ncbi.nlm.nih.gov/30823952/)

[Roberts BM et al., Parvalbumin interneurons and sensory processing (2019)](https://pubmed.ncbi.nlm.nih.gov/31666355/)

[Campbell SL et al., Parvalbumin neurons in stress and anxiety (2020)](https://pubmed.ncbi.nlm.nih.gov/32081303/)

[Cunningham DC et al., Parvalbumin interneuron deficits in aging brain (2020)](https://pubmed.ncbi.nlm.nih.gov/32876147/)

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

[Prefrontal sensory gating circuit restoration via PV interneuron enhancement](/hypothesis/h-62f9fc90) — <span style="color:#81c784;font-weight:600">0.69</span> · Target: PVALB

Pathway Diagram

The following diagram shows the key molecular relationships involving PVALB Gene - Parvalbumin discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

PVALB

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-pvalb
kg_node_id	PVALB
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-65a4a65c17cc
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-pvalb'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

36

Outgoing

64

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

PVALB Gene - Parvalbumin

PVALB Gene - Parvalbumin

Introduction

PVALB Gene - Parvalbumin

Introduction

Overview

Molecular Function

Protein Structure

Calcium Buffering

Cellular Mechanisms

Role in Neurodegenerative Diseases

Alzheimer's Disease

Interneuron Vulnerability

Mechanisms of Dysfunction

Circuit-Level Changes

Cognitive Implications

Therapeutic Strategies

Parkinson's Disease

Striatal Involvement

Pathological Changes

Circuit Dysfunction

Non-Motor Symptoms

Schizophrenia

Postmortem Findings

Functional Implications

Molecular Mechanisms

Epilepsy

Seizure-Associated Changes

Mechanisms

Therapeutic Implications

Other Neurological Disorders

Multiple System Atrophy

Huntington's Disease

Autism Spectrum Disorder

Expression Pattern

Brain Regional Distribution

Cellular Characteristics of PV+ Interneurons

Therapeutic Implications

Therapeutic Targets

Small Molecule Approaches

Genetic Approaches

Cell-Based Therapy

Device-Based Approaches

Biomarker Potential

Research Directions

Animal Models

Mouse Models

Key Findings from Animal Studies

Protein Interactions

Calcium-Related Interactions

Signaling Pathways

Interaction with Disease Proteins

Clinical Significance

Diagnostic Relevance

Therapeutic Targeting

Research Applications

Evolutionary Conservation

Species Conservation

Neuroimaging Findings

PET Imaging Studies

MRI Findings

Neurophysiology

Electrophysiological Characteristics

Gamma Oscillation Generation

Circuit Mechanisms

Sleep and Circadian Function

Sleep Architecture

Circadian Regulation

Aging and senescence

Age-Related Changes

Interventions

Research Methods

Experimental Approaches

Biomarkers and Markers

See Also

References

Related Hypotheses

Pathway Diagram

💬 Discussion